A Clinical Trial Comparing Tapering Doses of Buprenorphine with Steady Doses for Chronic Pain and Co-existent Opioid Addiction.
about
Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms.Toward a systematic approach to opioid rotation.The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.Chronic pain and depression among primary care patients treated with buprenorphineAdding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured WorkersA preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.Optimizing pain management through collaborations with behavioral and addiction medicine in primary care.Pain and motives for use among non-treatment seeking individuals with prescription opioid dependenceWithdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.Sublingual buprenorphine as an analgesic in chronic pain: a systematic review.Opioids and Chronic Pain: Where Is the Balance?The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.Outpatient Detoxification Completion and One-Month Outcomes for Opioid Dependence: A Preliminary Study of a Neuropsychoanalytic Treatment in Pain Patients and Addicted Patients
P2860
Q24598228-BAE47D38-74A0-40BA-8D16-76BCACC5CE8DQ34021146-21BB0C42-E944-4D20-9A21-64A40BC6040CQ34394425-72EB4AB1-E857-4169-8AD9-23D10CFFA319Q35491054-23524E7D-550D-48C9-8482-AC42CAC1E117Q35752692-11C3CD4A-F1E6-4B2E-8653-C1EEA1F513A3Q36424264-8F2BB220-CD96-4DDD-BB2C-AA478C7772A1Q36706966-AE99A393-8BE0-4728-8165-399F27039DFCQ36779246-AE173CE3-0CBC-41C2-BC90-C7327A7B2E70Q36914314-A3A44DD6-4242-4DAB-ADF7-102260AC5683Q37107666-0AA941A3-34EA-44D9-8491-BFA7671BFD58Q37420079-1981DF47-91F1-4604-891D-BB16315EAE03Q38226336-CF08CD92-19F1-4794-BF0B-BAFE78BEBE34Q38998329-5DFA4E56-1AE4-427A-A9B4-4CE5535D0670Q41996190-19A71CA4-0A25-40AA-9157-71E51D3A9915Q57399783-0EE4EF48-1DB4-4AB3-94E5-E10CCA3F61F6
P2860
A Clinical Trial Comparing Tapering Doses of Buprenorphine with Steady Doses for Chronic Pain and Co-existent Opioid Addiction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@ast
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@en
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@nl
type
label
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@ast
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@en
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@nl
prefLabel
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@ast
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@en
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@nl
P2093
P2860
P1476
A Clinical Trial Comparing Tap ...... Co-existent Opioid Addiction.
@en
P2093
Amy L Zielinski
Christina M Dambra
Daniel M Salcedo
Elisa M Foschio
Lisham Ashrafioun
Richard D Blondell
P2860
P304
P356
10.1097/ADM.0B013E3181BA895D
P577
2010-09-01T00:00:00Z